# SYNTHESIS Multi-Persona Review (Round 12): The Integrity Deep-Dive

This review evaluates the robustness of the Fail-Safe SE propagation and the versatility of the Clinical Impact layer.

---

## 1. The Methodologist (Cochrane Bias Methods Group)
**Focus:** Standard Error (SE) Propagation in Fallbacks.

> "When the Fail-Safe triggers, the system correctly switches the point estimate to the **TGEP Anchor**. However, currently, the 'Final Decision' list doesn't explicitly propagate the **TGEP Bootstrap SE**. 
>
> **The Improvement:** If we fallback to the Anchor, the reported confidence interval must also fallback to the robust bootstrap interval. We cannot report a 'Robust Estimate' with an 'Unstable SE'. The `decision` object must include a `final_se` and `final_ci`."

---

## 2. The Clinical Epidemiologist
**Focus:** The Versatility of Impact Metrics.

> "The current Clinical Impact layer assumes all data is a Log Odds Ratio. But what if I'm analyzing Mean Differences (MD) or Hazard Ratios (HR)? 
>
> **The Improvement:** We need a **'Measure Detector'**. The system should look at the range and distribution of effect sizes. If the values are large (e.g., > 5), it's likely a Mean Difference, not a Log-Ratio. We should add a `measure` parameter to `synthesis_audit` to allow users to specify 'OR', 'RR', 'MD', or 'SMD', and adjust the Clinical Impact math accordingly."

---

## 3. The Data Engineer (Big Data/ETL)
**Focus:** The "Purified" Data Export.

> "We are calculating beautiful 7-layer weights, but they stay in the R object.
>
> **The Improvement:** `synthesis_table()` should include a column for the **'Purified Effect'** ($yi_{raw} 	imes Weight$). This allows users to export the weighted dataset into other visualization tools like Tableau or PowerBI to show how SYNTHESIS shifted the individual studies."

---

## 4. The Quality Assurance Lead (Software Testing)
**Focus:** Edge Case Stability.

> "The Trajectory Confidence is currently `(1 - p) * 100`. In a dataset with 3 studies where they are perfectly aligned, the p-value might be tiny, giving 99.9% confidence. But with $k=3$, that confidence is statistically illusory.
>
> **The Improvement:** We should apply a **'Small-Sample Dampener'** to the Trajectory Confidence. Multiply the confidence by $\min(1, k/15)$. This forces the model to be 'Humble' when the sample size is small, even if the fit looks perfect."

---

## Final Synthesis Improvement Plan (Round 12)
1.  **Robust Fallback SE**: Update `synthesis_audit` to include `final_se` and `final_ci` in the decision output, correctly sourcing from TGEP if Fail-Safe is active.
2.  **Adaptive Impact Math**: Add `measure` support ('Ratio' vs 'Difference') to the Clinical Impact layer.
3.  **The Humility Factor**: Apply the $k/15$ dampener to Trajectory Confidence.
4.  **Purified Data Column**: Add the 'Weighted Contribution' to the transparency table.

---
*Review conducted by Gemini CLI Multi-Persona Protocol, Feb 2026.*
